Predictive Oncology Inc.
NASDAQ: POAI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Raymond F. Vennare
- Employees
- 23
- Headquarters
- Pittsburgh, United States
- IPO year
- 2010
- Market cap
- $3.6M
- Website
- https://www.predictive-oncology.com
Loading POAI…
Loading profile data…Frequently asked questions about POAI
What does Predictive Oncology Inc. (POAI) do?
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline. The Helom...
Where does POAI trade?
Predictive Oncology Inc. (POAI) trades on the NASDAQ Capital Market.
What sector is POAI in?
Predictive Oncology Inc. (POAI) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Predictive Oncology Inc.?
Raymond F. Vennare is the chief executive officer of Predictive Oncology Inc. (POAI).
Where is Predictive Oncology Inc. headquartered?
Predictive Oncology Inc. is headquartered in United States.
Does POAI pay a dividend?
Predictive Oncology Inc. (POAI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did POAI go public?
Predictive Oncology Inc. (POAI) completed its initial public offering in 2010.